Clinical Trial of Intranasal Delivery of NT-301

Clinical trial NCT06954428 · COMPLETED

Trial details

NCT number: NCT06954428
Sponsor: Nano PharmaSolutions Australia
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tolerability of NT-301 Nasal Spray Pharmacokinetics of NT-301 Nasal Spray Safety of NT-301 Nasal Spray Performance of NT-301 Nasal Spray Device

Start date: 2025-06-20
Primary completion: 2025-12-12
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.